Literature DB >> 1747050

Depletion of dietary arginine inhibits growth of metastatic tumor.

T J Yeatman1, G L Risley, M E Brunson.   

Abstract

The effects of dietary arginine on the growth of a murine colon tumor metastatic to the liver were examined in a model of advanced neoplastic disease. Tumor growth was influenced by arginine both in vivo and in vitro. An arginine-supplemented diet stimulated tumor growth by 55% compared with controls. Conversely, an arginine-depleted diet inhibited tumor growth by 78% compared with controls. In vitro culture of both murine and human colon tumor cells confirmed that arginine was necessary for cell growth. Flow-cytometric analysis using propidium iodide and bromodeoxyuridine suggested that colon tumor cells cultured without arginine enter a quiescent S phase and depend on arginine for further growth and cell cycle progression. The potential roles for selective dietary arginine modulation in patients with cancer with advanced disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747050     DOI: 10.1001/archsurg.1991.01410350066010

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  13 in total

1.  Argininosuccinate synthase: at the center of arginine metabolism.

Authors:  Ricci J Haines; Laura C Pendleton; Duane C Eichler
Journal:  Int J Biochem Mol Biol       Date:  2011

2.  Arginine-supplemented enteral nutrition.

Authors:  Jutta Huebner; Ralph Muecke
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-13       Impact factor: 4.553

Review 3.  New insights into male (in)fertility: the importance of NO.

Authors:  B Buzadzic; M Vucetic; A Jankovic; A Stancic; A Korac; B Korac; V Otasevic
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

4.  Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase.

Authors:  Tawnya L Bowles; Randie Kim; Joseph Galante; Colin M Parsons; Subbulakshmi Virudachalam; Hsing-Jien Kung; Richard J Bold
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

Review 5.  Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment.

Authors:  Neha Kumari; Saurabh Bansal
Journal:  Cancer Chemother Pharmacol       Date:  2021-07-26       Impact factor: 3.333

Review 6.  Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges.

Authors:  Melissa M Phillips; Michael T Sheaff; Peter W Szlosarek
Journal:  Cancer Res Treat       Date:  2013-12-31       Impact factor: 4.679

7.  Role of arginine and its methylated derivatives in cancer biology and treatment.

Authors:  Bela Szende; Erno Tyihák; Lajos Trézl
Journal:  Cancer Cell Int       Date:  2001-12-17       Impact factor: 5.722

8.  Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells.

Authors:  L Scott; J Lamb; S Smith; D N Wheatley
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

9.  Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines.

Authors:  Yan-Shen Shan; Hui-Ping Hsu; Ming-Derg Lai; Meng-Chi Yen; Wei-Ching Chen; Jung-Hua Fang; Tzu-Yang Weng; Yi-Ling Chen
Journal:  Sci Rep       Date:  2015-04-30       Impact factor: 4.379

10.  Graphene Functionalized with Arginine Decreases the Development of Glioblastoma Multiforme Tumor in a Gene-Dependent Manner.

Authors:  Ewa Sawosz; Sławomir Jaworski; Marta Kutwin; Krishna Prasad Vadalasetty; Marta Grodzik; Mateusz Wierzbicki; Natalia Kurantowicz; Barbara Strojny; Anna Hotowy; Ludwika Lipińska; Joanna Jagiełło; André Chwalibog
Journal:  Int J Mol Sci       Date:  2015-10-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.